This suggests that overactivation of the TLR3–ET-1 axis may play a role in the itch–scratch cycle, and hence, in the pathogenesis of these diseases [251], as well as in the elevation of blood β-endorphin levels of AD patients (see below). Here, TLR3 is linked to Alzheimer disease.